TABLE 5.
Multiplicative effects with 95% confidence intervals of disease severity categories and age on median salivary antibody responses to SARS-CoV-2 proteins from generalized additive models, adjusted for a spline function of interval from the onset
| Parameter | Spike protein EPA_S |
Nucleocapsid protein AB_N |
Spike stalk subunit PS_S2i |
Receptor binding domain EPA_RBD |
||||
|---|---|---|---|---|---|---|---|---|
| Multiplicative effect | P value | Multiplicative effect | P value | Multiplicative effect | P value | Multiplicative effect | P value | |
| Severity of symptoms | ||||||||
| Asymptomatic | Reference | Reference | Reference | Reference | ||||
| Mild | 3.28 (1.43–7.53) | 0.005 | 2.79 (1.10–7.10) | 0.03 | 3.69 (1.58–8.61) | 0.003 | 2.35 (1.01–5.47) | 0.05 |
| Moderate | 5.32 (2.31–12.3) | <0.0001 | 4.68 (1.83–12.0) | 0.001 | 5.94 (2.53–13.9) | <0.0001 | 4.09 (1.75–9.55) | 0.001 |
| Severe | 8.03 (1.86–34.7) | 0.01 | 8.28 (1.59–43.0) | 0.01 | 11.6 (2.59–51.5) | 0.001 | 5.66 (1.28–25.1) | 0.02 |
| Age, per 10-yr increase | 1.05 (0.92–1.19) | 0.5 | 1.30 (1.12–1.51) | 0.0004 | 1.12 (0.98–1.28) | 0.10 | 1.14 (1.00–1.31) | 0.05 |
| Spline of interval from onset |
NAa | 0.0004 | NA | 0.0005 | NA | <0.0001 | NA | 0.15 |
NA, not applicable.